⌘K

Home/Filings/4/0001209191-18-036751

4//SEC Filing

Friedman Bart 4

Accession 0001209191-18-036751

CIK 0001636651other

View on SEC.gov Company Profile

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 5:43 PM ET

Size

5.3 KB

Accession

0001209191-18-036751

Insider Transaction Report

Form 4

Period: 2018-06-07

Ovid Therapeutics Inc.OVID

Director

Transactions

Award
Stock Option (Right to Buy)
2018-06-07+5,813→ 5,813 total
Exercise: $8.12Exp: 2028-06-06→ Common Stock (5,813 underlying)

Footnotes (1)

[F1]The option will vest in full on June 7, 2019, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1

filerCIK 0001368324

Filing Metadata

Form type: 4
Filed: Jun 7, 8:00 PM ET
Accepted: Jun 8, 5:43 PM ET
Size: 5.3 KB

View on SEC.gov